共 221 条
[31]
Aissaoui H(1996)Effects of cisapride on abnormally prolonged endogastric alkalinity time and delayed gastric emptying in cirrhotic patients Hepatogastroenterology. 43 1678-2397
[32]
Flores S(1998)Abnormal gastric motility in liver cirrhosis: roles of secretin Dig Dis Sci. 43 2392-169
[33]
Hoever P(2014)A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls PLoS ONE 9 e97885-383
[34]
Dorffner G(2014)CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores Br J Clin Pharmacol. 77 160-1674
[35]
Beneš H(2016)An update on the role of intestinal cytochrome P450 enzymes in drug disposition Acta Pharm Sin B. 6 374-1161
[36]
Penzel T(1993)Comparative binding of bile acids to serum lipoproteins and albumin J Lipid Res. 34 1661-653
[37]
Danker-Hopfe H(2008)Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction Eur J Clin Pharmacol. 64 1147-757
[38]
Barbanoj MJ(1984)Decreased alpha 1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding Br J Clin Pharmacol. 18 652-1037
[39]
Dauvilliers Y(1987)Pharmacokinetics of erythromycin in patients with severe cirrhosis: respective influence of decreased serum binding and impaired liver metabolic capacity Br J Clin Pharmacol. 23 753-8
[40]
Zammit G(1986)Phenytoin kinetics during pregnancy and the puerperium Br J Obstet Gynaecol. 93 1030-359